Synergistic effect of ezetimibe addition on coronary atheroma regression in patients with prior statin therapy: Subanalysis of PRECISE-IVUS trial

Conclusion
Compensatory increase in cholesterol absorption observed in statin-treated patients might attenuate the inhibitory effects of statins on coronary plaque progression. A low-dose statin/ezetimibe combination might be a promising option in statin-hyporesponder.

Source: European Journal of Preventive Cardiology - August 29, 2016 Category: Cardiology Authors: Tsujita, K., Yamanaga, K., Komura, N., Sakamoto, K., Sugiyama, S., Sumida, H., Shimomura, H., Yamashita, T., Oka, H., Nakao, K., Nakamura, S., Ishihara, M., Matsui, K., Sakaino, N., Nakamura, N., Yamamoto, N., Koide, S., Matsumura, T., Fujimoto, K., Tsuno Tags: Short Report Source Type: research